Acceleron Pharma is a biopharmaceutical company focused on developing protein therapeutics for unmet medical needs, particularly in the areas of cancer and rare diseases. They are known for their work with growth and differentiation factors and have several drug candidates in development, including Sotatercept for pulmonary arterial hypertension. The company was founded in 2003 and acquired by Merk in 2021.